Neurocrine Biosciences’ schizophrenia program pivot has failed. The biotech was unable to replicate the cognition signal it saw in an earlier midphase study, prompting it to stop development of ...

Delusions are often a sign of an underlying mental health disorder, such as schizophrenia, bipolar disorder, dementia, or delusional disorder. Delusions can also be a sign of brain injury, ...

Schizophrenia, a severe psychiatric disorder affecting about 1% of the population, has long been known to have both genetic and environmental roots. Recent years have seen explosive growth in our ...

Summary: Researchers have identified a mechanism that impairs synaptic plasticity in individuals with schizophrenia, revealing the role of three key proteins. Using computational modeling, the team ...

NEW YORK, Aug. 29 (UPI) --People with schizophrenia have been challenging the ongoing stigma tied to their mental disorder by posting on social media, trying to dispel the myth that they're prone ...

The Phase II clinical study assessed NBI-1117568 as an oral treatment for schizophrenia. Credit: NTshutterth/Shutterstock. Neurocrine Biosciences has reported ...

Aug 28 (Reuters) - Neurocrine Biosciences (NBIX.O), opens new tab said on Wednesday its drug helped reduce the severity of schizophrenia symptoms in a mid-stage trial, but its shares fell nearly ...

Speak with Dead is easily one of the most interesting spells in Baldur's Gate 3, but it feels even more powerful and harrowing when cast by a necromancer. For those who are unaware, the spell ...

Schizoid personality disorder can include constant daydreaming, but unlike schizophrenia, the daydreaming of schizoid personality disorder does not include hallucinations or a complete disconnect with ...